Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind active-controlled trial of Group A meningococcal polysaccharide vaccine in healthy infants aged 6 to 15 months
CTR20201830Phase 3Active
- Sponsor
- Institute of Medical Biology Chinese Academy of Medical Sciences
- Start
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of group a meningococcal polysaccharide vaccine in meningococcal meningitis, sponsored by Institute of Medical Biology Chinese Academy of Medical Sciences. Started Sep 2020; status: active.
02
Drugs
group a meningococcal polysaccharide vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20201830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201830.